← Back
Data updated: Mar 10, 2026
G AND W LABS INC
DermatologyNeurologyImmunology
G AND W LABS INC is a generic drug manufacturer focused on Dermatology, Neurology, Immunology. Key products include FLUOXETINE HYDROCHLORIDE.
1982
Since
12
Drugs
-
Trials
130
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NYSTATIN 2026-02-05
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
SELEGILINE HYDROCHLORIDE 2025-09-04
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 25%
1 drugs
Neurology 25%
1 drugs
Immunology 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Dermatology, Immunology, Gastroenterology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Neurology
BAUSCH specialty
Dermatology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology, Neurology
Discontinued (8)
Company Info
- First Approval
- 1982-07-14
- Latest
- 2019-07-05
- Applications
- 12
FDA Sponsor Names
G AND W LABS INCG AND W LABS